DeviceTalks Minnesota

Check in, choose the session you would like to attend and grab a refreshment. 

Medtronic’s Steve Oesterle said in 2014 that the next great competitors his company won’t be Boston Scientific or St. Jude Medical but tech giants like Google. Stockpiled with cash and willing to take on the biggest healthcare problems, Google is both pushing medtech into deeper blue ocean and forging a path for a new era of innovation.

 

Through its high profile partnerships in the diabetes space with recent partnerships in the diabetes space with companies like DexCom, Sanolfi or its robotic surgery efforts with Johnson & Johnson, Google is signaling that it believes the future of medtech innovation will be forged through strategic partnerships with companies outside of the industry.

 

While this paradigm is not new in biotech and pharmaceuticals, convergence is still new to medtech. However, the industry must continue look for new pathways to expand care without sacrificing quality.

 

In this mini “hackathon”  (A 2-hour brainstorming and networking workshop) led by experts from MPR Product Development and Halloran Consultants, we will: 

 

• Examine the landscape for convergence opportunities that will change medtech now and in the future

 

• Highlight the challenges and opportunities for cross industry convergence

 

• Identify the challenges that must be solved by the industry in the short term to compete in the changing business landscape from the product development, regulatory and quality standpoint

 

• Learn about industry partnerships and mergers that will reshape the landscape of healthcare. What has worked and what has not

 

• Establish an understanding of the innovative technologies created by the merger of current technologies and best practices

 

• Brainstorm with peers to evaluate and co-create potential industry changing concepts

 

• Energize your business ecosystem by collaborating with potential partners

 

 

·         What every medtech company needs to know about products liability litigation  

·         M&A trends from the perspective of both acquirer and seller

·         IP protection is key to a successful exit

Marie Johnson's path to entrepreneurship was set by the death of her husband from a sudden heart attack from coronary artery disease at the age of 41.  Johnson, a doctorate student and mother of two young children, turned her grief into a mission to find out why a seemingly healthy man in the prime of his life would be strken by a prevenatable death. Thirteen years later, Johnson's Aum Cardiovascular's CADence device, which uses sensors and algorithms to identify blockages in arteries is on the market in Germany and soon the U.S. In an intimate interview we'll learn all about Johnson's journey. 

And as a bonus interview, medtech legend Manny Villafana, founder of St. Jude Medical, Guidant, AMS and more will talk to us about what happened at Kips Bay Medical, which recently closed its doors after running out of cash. Vilafana will speak frankly about the company and why it failed to succeed where so many others did. 

Shaye Mandle, President/CEO, LifeScience Alley leads a panel of CEOs from the Minnesota community that are at exciting moments in their development. We'll discuss the challenges and opportunities that face these firms including: 

• Deciding when/where to go public when raising funding
• Managing the commercialization challenges 
• Positioning the company for growth
• Managing the mergers and acquisitions game from the perspective of the acquired and the acquirer. 
• What's next for these companies